1. Home
  2. NUTX vs TVGN Comparison

NUTX vs TVGN Comparison

Compare NUTX & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$203.40

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$7.81

Market Cap

21.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
TVGN
Founded
2011
2020
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Blank Checks
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
21.3M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NUTX
TVGN
Price
$203.40
$7.81
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$252.50
N/A
AVG Volume (30 Days)
121.6K
6.5K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
N/A
EPS
15.87
N/A
Revenue
$875,257,000.00
N/A
Revenue This Year
$6.12
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
$13.16
N/A
Revenue Growth
82.36
N/A
52 Week Low
$83.99
$0.14
52 Week High
$224.28
$12.03

Technical Indicators

Market Signals
Indicator
NUTX
TVGN
Relative Strength Index (RSI) 57.10 63.21
Support Level $142.71 $6.22
Resistance Level $224.28 $7.90
Average True Range (ATR) 10.32 0.42
MACD -0.59 0.02
Stochastic Oscillator 54.47 91.00

Price Performance

Historical Comparison
NUTX
TVGN

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: